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Abstract
Identifying the genes causing male infertility is important to increase our biological understanding as well as the diagnos-
tic yield and clinical relevance of genetic testing in this disorder. While significant progress has been made in some areas, 
mainly in our knowledge of the genes underlying rare qualitative sperm defects, the same cannot be said for the genetics 
of quantitative sperm defects. Technological advances and approaches in genomics are critical for the process of disease 
gene identification. In this review we highlight the impact of various technological developments on male infertility gene 
discovery as well as functional validation, going from the past to the present and the future. In particular, we draw attention 
to the use of unbiased genomics approaches, the development of increasingly relevant functional assays and the importance 
of large-scale international collaboration to advance disease gene identification in male infertility.
Introduction
Infertility is a complex pathological condition that affects 
close to 7% of the global male human population and pre-
sents as a wide range of heterogeneous phenotypes, from 
congenital or acquired urogenital abnormalities, endocrine 
disturbances and immunological factors to spermatogenic 
quantitative and qualitative defects (Krausz 2011; Tour-
naye et al. 2017). While severe forms of infertility cannot 
be directly inherited—by default an affected man is incapa-
ble of naturally passing on his genetic information (unless 
facilitated by assisted reproductive technologies)—genetics 
plays a major role in this disorder. Unaffected parents can 
for example pass on genetic mutations that result in autoso-
mal recessive or X-linked forms of male infertility (Chillón 
et al. 1995; Yatsenko et al. 2015). In addition, many muta-
tional events take place during normal gametogenesis that 
can result in germline de novo mutations (DNMs), de novo 
copy number variations (CNVs) or de novo chromosomal 
abnormalities, some of which can result in male infertility 
in the offspring (Jacobs and Strong 1959; Reijo et al. 1995; 
Sun et al. 1999).
In approximately 15% of infertile men a genetic defect is 
most likely the underlying cause of the pathology (Tournaye 
et al. 2017; Krausz and Riera-Escamilla 2018). However, 
despite widespread usage of karyotyping, azoospermia fac-
tor (AZF) deletion screening and cystic fibrosis transmem-
brane conductance regulator (CFTR) mutation analysis, a 
recent study in a large unselected patient cohort revealed a 
causal genetic diagnosis in only 4% of infertile men (Tüttel-
mann et al. 2018). Similar to what has been found for other 
disorders, genetics is found to play a more prominent role 
in the most severe forms of spermatogenic impairment such 
as severe oligozoospermia (< 5 million sperm cells per ml) 
or azoospermia (no sperm in ejaculate) (Lopes et al. 2013; 
Krausz and Riera-Escamilla 2018).
The identification of genetic causes of male infertility, 
which began in the middle of the twentieth century, contin-
ues to this day aided by the development of novel molecu-
lar techniques and technological advancements that have 
allowed for the discovery and characterisation of key genes 
responsible for the various subtypes of human male infertil-
ity (Fig. 1). Although evidence for a genetic cause of male 
infertility was first reported in the 1950s, when an extra X 
chromosome was found in patients diagnosed with Kline-
felter Syndrome, it was not until the late 1990s that research 
efforts were intensified to search for additional genetic 
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factors, initially focusing on specific deletions and muta-
tions in the androgen receptor and the CFTR gene (Dumur 
et al. 1990; Akin et al. 1991; McPhaul et al. 1992; Patrizio 
et al. 1993) and Y chromosomal abnormalities (Vogt et al. 
1992; Reijo et al. 1995). In recent years, researchers have 
increasingly applied array-based genome-wide approaches 
and, more recently, next-generation sequencing (NGS) 
technologies to perform more unbiased genomic studies in 
male infertility and identify numerous male infertility genes 
(Aston and Carrell 2009; Talkowski et al. 2011; Tüttelmann 
et al. 2011; Ayhan et al. 2014).
In this review, we contextualise how different technologi-
cal advances have contributed to our understanding of the 
genetics of male infertility, detailing current shortcomings 
and challenges. We conclude by providing some perspective 
on future directions and a call-to-arms among researchers, 
clinicians and patients for stronger collaboration and sharing 
of information for the benefit of all.
The past: chromosome studies and specific 
gene analysis revealed the first male 
infertility genes
Chromosomal abnormalities causing male infertility
Karyotyping was the first test employed to investigate the 
presence of genetic abnormalities in infertile men and to this 
day remains the most widely used diagnostic test in male 
infertility. This cytogenetic technique revealed several very 
important chromosomal abnormalities associated to male 
infertility, with the most common being the presence of an 
additional X chromosome (47, XXY) which characterises 
Klinefelter syndrome (Jacobs and Strong 1959), present in 
15% of non-obstructive azoospermic patients (Ferlin et al. 
2006a; Jungwirth et al. 2012; Punab et al. 2016; Vockel et al. 
2019). The combination of karyotype analysis with fluo-
rescence in situ hybridisation (FISH) revealed additional 
chromosomal abnormalities to underlie primary infertility 
and sex development disorders, specifically 46, XX male; 
Robertsonian and reciprocal translocations (Therkelsen 
1964; Chapelle et al. 1964; Hamerton 1968; Koulischer and 
Schoysman 1974; Jacobs et al. 1975).
Karyotype analysis was also essential to identify the loca-
tion of genetic factors controlling normal spermatogenesis. It 
was through the usage of this technique that in 1976 a dele-
tion at the distal portion of band q11 of the Y chromosome 
was found in 6 men with azoospermia and the region was 
identified as essential for spermatogenesis (Tiepolo and Zuf-
fardi 1976). Although this pointed to the presence of a gene 
or genes controlling human spermatogenesis in this deleted 
portion of the Y chromosome, it was not until the 1990s that 
the first gene directly involved in spermatogenic failure was 
identified by novel molecular technologies.
The search for the azoospermia factor (AZF) within the 
deleted regions of the Y chromosome involved the use of 
polymerase chain reaction (PCR) analysis and Y-specific 
sequence-tagged sites (STSs) to identify potential candi-
date genes (Ma et al. 1992, 1993; Kobayashi et al. 1994). 
Appropriately, the strongest candidate gene found to be 
Fig. 1  Timeline of the discovery of key genes involved in male infer-
tility. The development of novel molecular techniques and techno-
logical advancements introduced since 1956 have allowed for the 
identification of key genes responsible for the various types of male 
infertility in humans. Although the first male infertility genes were 
first identified in the late 1980s, the widespread application of micro-
array and NGS approaches has resulted in an increase in the detection 
of male infertility genes
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absent in the azoospermic men with Y microdeletions was 
named Deleted in Azoospermia or DAZ (Reijo et al. 1995, 
1996; Vogt 1998; Ferlin et al. 1999), of which four paralogs 
(DAZ1-4) have now been identified on the Y chromosome 
(Saxena et al. 2000). Further application of these PCR-
based techniques revealed three genomic regions on the Y 
chromosome frequently deleted in men with spermatogenic 
failure, named AZF regions a, b, and c (Vogt 1998). Each 
of these regions contains candidate genes highly or exclu-
sively expressed in the testis and essential in spermatogen-
esis, including BPY2, CDY, DAZ, HSFY, RBMY, PRY, TSPY; 
VCY and XKRY (Reijo et al. 1995; Elliott et al. 1997; Lahn 
and Page 1997; Yen 1998; Sun et al. 1999; Skaletsky et al. 
2003; Krausz and Casamonti 2017). Microdeletions affect-
ing AZF regions result in a variable phenotype, ranging from 
oligozoospermia to azoospermia in 2–10% in infertile men 
(Krausz and Riera-Escamilla 2018). However, the genetic 
causes for the infertility of most men remained unknown, 
requiring scientists to look elsewhere in the genome.
Identification of specific gene mutations resulting 
in male infertility
The first gene linked to male infertility outside of the Y 
chromosome was identified in 1988 on chromosome X. At 
the time, mutations in the murine androgen receptor gene, 
mapped via linkage analysis to the X chromosome, had 
already been well established to cause testicular feminisation 
in mice (Lyon and Hawkes 1970). Based on this information, 
Brown et al. used a PCR-based approach coupled with south-
ern blotting to reveal that deletion of the human Androgen 
Receptor (AR, also known as NR3C4) was responsible for 
infertility in patients with mild or partial androgen insen-
sitivity syndrome, as well as sex reversal in patients with 
complete androgen insensitivity syndrome (Brown et al. 
1988). Initially, PCR-amplified exons of the AR gene were 
screened for mutations using techniques such as denatur-
ing gradient gel electrophoresis (DGGE) and single-strand 
conformational polymorphism analysis (SSCP) and by dena-
turing high performance liquid chromatography (DHPLC) 
screening (Quigley et al. 1995; Ferlin et al. 2006b). Since 
the gene was first linked to male infertility, mutations in AR 
have been identified in 2% of infertile men causing either 
mild or partial androgen insensitivity syndrome (McPhaul 
et al. 1992; Ferlin et al. 2006b; Gottlieb et al. 2012; Vockel 
et al. 2019).
In 1989, mutations in the CFTR gene (Cystic Fibrosis 
Transmembrane Conductance Regulator) on chromosome 
7 were discovered to underlie Cystic Fibrosis, using restric-
tion fragment length polymorphism (RFLP) analysis to 
pinpoint the genomic locus of interest followed by PCR-
based sequencing to identify mutations (Kerem et al. 1989; 
Riordan et al. 1989). Since the original reporting, further 
studies have identified specific mutations in this gene 
responsible for isolated infertility. In particular, mutations 
in CFTR have been found to cause obstructive azoospermia 
as a result of Congenital Bilateral Absence of the Vas Defer-
ens using DGGE and SSCP techniques (Dumur et al. 1990; 
Anguiano 1992; Culard et al. 1994). The high prevalence 
of CFTR mutations in the global population, particularly 
in individuals of European descent where 1 in 25 are carri-
ers of pathogenic variants, explains why CFTR gene muta-
tions cause 60–70% of congenital absence of the vas defer-
ens (CAVD) cases (Weiske et al. 2000). Overall, however, 
CAVDs is a rare condition found in only 1–2% of all infertile 
men (Bieth et al. 2020).
Optimization and upscaling of Sanger sequencing on 
automated DNA sequencers resulted in wide-scale adoption 
of DNA sequencing in human disease research and diagnos-
tics in the early 2000s (Metzker 2005; Hutchison 2007). It 
was particularly successful in testing for mutations in can-
didate disease genes identified by either positional cloning 
or by evidence from orthologous genes studied in model 
organisms. A good example of this was shown by the identi-
fication of mutations in SYCP3 gene related to meiotic arrest 
during spermatogenesis (Miyamoto et al. 2003). The role of 
this gene in male infertility had been previously established 
in mice where male homozygous null mutants for the Sycp3 
gene were found to be infertile due to massive apoptotic cell 
loss during spermatogenesis (Yuan et al. 2000). After isola-
tion of the human SYCP3 gene it was found to have an iden-
tical function and similar negative consequences to human 
fertility if disrupted (Martinez-Garay et al. 2002; Miyamoto 
et al. 2003). Of note, while in mice bi-allelic mutations are 
required to reveal an infertility phenotype, in humans a sin-
gle heterozygous mutation in SYCP3 is sufficient to compro-
mise spermatogenesis.
The present: technological advances 
allowing unbiased analysis of the infertile 
genome
Genome‑wide homozygosity screening using 
microsatellite scans and SNP microarrays
Adaptations made to existing sequencing technology as well 
as the introduction of single nucleotide polymorphism (SNP) 
microarrays in the 1990s permitted once more a shift in the 
research approaches available to investigate the genomes of 
infertile men and identify novel genes associated with male 
infertility. Initially, this work was focused on developing 
and applying large sets of polymorphic markers to screen 
genomes of infertile men from consanguineous descent for 
regions of homozygosity. In 2007, this new positional clon-
ing approach resulted in the identification of two novel male 
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infertility genes, AURKC and SPATA16, causing multiple 
morphological sperm abnormalities (Dieterich et al. 2007; 
Dam et al. 2007). Similarly, homozygosity mapping was 
used to identify an homozygous variant in DNAH1 in a small 
cohort of infertile men with morphological abnormalities in 
their sperm flagella (Ben Khelifa et al. 2014).
Microarray‑based detection of genomic copy 
number variation
While structural variants such as CNVs present on the Y 
chromosome have been clearly shown to have a negative 
effect on spermatogenesis (Nathanson et al. 2005; Visser 
et al. 2009; Krausz and Casamonti 2017), only few other 
structural genomic variations have been robustly linked to 
male infertility. Microarray-based comparative genomic 
hybridization (array CGH) and SNP arrays have dramatically 
increased the detection resolution of genomic deletions and 
duplications since the late 90 s (Solinas-Toldo et al. 1997; 
Pinkel et al. 1998).
The application of SNP microarray technology revealed 
one important CNV associated with male infertility in 2011, 
a 200 kb homozygous deletion affecting the DPY19L2 gene 
(Harbuz et al. 2011; Koscinski et al. 2011). Specific ampli-
fication and sequencing of DPY19L2 was initially ham-
pered by the presence of a pseudogene. In 2012, Coutton 
et al. optimized the conditions to specifically amplify and 
sequence this gene and identified globozoospermia patients 
with a combination of a deletion and a nonsense or mis-
sense mutation, as well as a patient with homozygous mis-
sense mutations (Coutton et al. 2012). Together, deletions 
and point mutations in DPY19L2 are now known to explain 
most cases of globozoospermia.
In 2011, Tüttelmann et al. employed microarray technol-
ogy to discover an excess of rare CNVs on the sex chromo-
somes of azoospermic and severe oligozoospermic German 
men (Tüttelmann et al. 2011), a signature that was later 
replicated in other populations (Stouffs et al. 2012; Krausz 
et al. 2012; Lopes et al. 2013; Lo Giacco et al. 2014). More 
recently, high-resolution array-CGH was used by Yatsenko 
et al. to identify an identical deletion of three exons of the 
TEX11 gene on chromosome X in two patients with azoo-
spermia. Sanger sequencing of this gene revealed additional 
pathogenic (truncating and splice) mutations in azoospermia 
patients (Yatsenko et al. 2015). Mutations in TEX11 were 
also reported in azoospermia patients by another group in 
the same year (Yang et al. 2015). Interestingly, this group 
decided to study TEX11 because they previously showed that 
male mice lacking this gene show meiotic arrest, resulting 
in azoospermia (Yang et al. 2008).
Using a similar microarray approach, recurrent deletions 
affecting the DMRT1 gene located on chromosomes 9 have 
been associated with azoospermia (Lopes et al. 2013; Lima 
et al. 2015). While putative pathogenic mutations in azoo-
spermic men have also been described in this gene (Tewes 
et al. 2014), it’s role in infertility is still not completely 
clear. The clinical relevance of other rare CNVs, reported 
in a limited number or even a single infertile man, remains 
uncertain. As an example, an approximately 1 Mb deletion 
found in a single azoospermic man was reported in 2014. 
The CNV on chromosome 11 spans nine genes, of which 
the WT1 gene was hypothesized as the potential cause for 
spermatogenic failure (Seabra et al. 2014). Another example 
involves an 11–15 kb deletion on chromosome X observed 
so far exclusively in azoospermic men from the Mediterra-
nean, causing a partial deletion of the proximal copy of the 
MAGEA9B gene (Lo Giacco et al. 2014; Shen et al. 2017).
While SNP and CGH microarrays have highlighted the 
important role of CNVs in male infertility, the widespread 
application of next-generation sequencing (NGS) now offers 
the opportunity to combine the detection of CNVs and other 
more complex structural variations with the simultane-
ous detection of SNVs (Zhou et al. 2018; Ho et al. 2019). 
Recently, a balanced reciprocal translocation affecting the 
SYCP2 gene was reported in a patient with severe oligo-
zoospermia, initially discovered by karyotyping but further 
characterized using both microarrays as well as NGS (Schilit 
et al. 2020). Interestingly, through international collabora-
tion, loss-of-function mutations affecting this gene were 
identified in an additional three infertile patients from Ger-
many, highlighting the importance of combining structural 
genomic variation and single nucleotide variation analysis 
as well as multi-institutional collaboration.
Next‑generation sequencing to detect new disease 
genes
The development of high-throughput NGS platforms in 
the past decade has resulted in a dramatic drop in sequenc-
ing costs and an equally dramatic increase in sequencing 
throughput. Rather than relying on the need to select and 
sequence individual candidate genes or evaluate specific pol-
ymorphisms or large structural defects in a small number of 
patients and controls, NGS allows for unbiased sequencing 
of large numbers of genes, all coding exons (whole exome 
sequencing) or sequencing of the entire human genome, and 
increasingly allows this to be done in very large cohorts of 
patients and controls. Accordingly, NGS has provided an 
inexpensive and rapid genetic screening approach to dis-
cover novel disease-associated genes (Boycott et al. 2013; 
Fernandez-Marmiesse et al. 2018). Figure 2 shows how in 
recent years exome sequencing has become the predominant 
technology used for disease gene studies in male infertility.
In Multiple Morphological Abnormalities of the Sperm 
Flagella (MMAF), exome sequencing of relatively small 
cohorts of patients has been particularly successful, resulting 
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in the identification of many important new recessive dis-
ease genes (Touré et al. 2020). Exome sequencing has also 
been successfully applied to identify new disease genes for 
patients with acephalic spermatozoa. In particular, homozy-
gous and compound heterozygous mutations in testis-spe-
cific genes BRDT, SUN5 and PMFBP1 (Zhu et al. 2016, 
2018; Li et al. 2017; Sha et al. 2019) have been found to dis-
rupt the head-flagella junction of the spermatozoa of these 
infertile men. In addition, NGS has also been instrumental 
in the study of congenital isolated hypogonadotropic hypo-
gonadism, characterised by incomplete or absent puberty 
and infertility. A large number of pathogenic mutations have 
been identified in genes and genetic loci that result in neu-
rodevelopmental defects of gonadotropic hormone-releasing 
hormone (GnRH) neuron migration or disrupt neuroendo-
crine GnRH secretion and action (Cangiano et al. 2020; Butz 
et al. 2020).
The investigation of the genetic basis for the much more 
common forms of non-obstructive azoospermia has proven 
to be more difficult, likely because of the enormous genetic 
heterogeneity resulting in a wide diversity of phenotypes 
encompassed in NOA, from the complete lack of germ cells 
(Sertoli cell only syndrome) to various forms of maturation 
arrest. Nevertheless, significant progress has been made on 
this front, where exome sequencing of azoospermic men 
in both consanguineous and non-consanguineous families 
has revealed pathogenic mutations in genes such as TEX15 
(Okutman et al. 2015), FANCM (Kasak et al. 2018), XRCC2 
(Yang et  al. 2018), MEIOB (Gershoni et  al. 2019) and 
FANCA (Krausz et al. 2019). In addition, exome sequencing 
revealed mutations in ADGRG2 in patients with congenital 
obstructive azoospermia (Patat et al. 2016). In conclusion, 
the widespread application of exome sequencing in azoo-
spermia and severe oligozoospermia is uncovering muta-
tions in many new candidate disease genes (see also Kasak 
and Laan 2020). At this stage, however, many of these new 
candidate genes have not been independently replicated and 
their role in quantitative sperm defects therefore remains to 
be established.
Clinical validity assessment of candidate infertility 
genes
Up to this point we have described the different approaches 
used to identify genetic variants associated with male infer-
tility. However, in order to convincingly link variants in a 
certain gene to disease, one needs to consider various levels 
of evidence. Incorrect and misleading conclusions about 
the role of genes in causing quantitative or qualitative sper-
matogenic defects could lead to inappropriate diagnoses and 
even mismanagement and counselling of couples. Further-
more, incorrectly characterized genes may impede follow-up 
research by contaminating candidate disease gene lists and 
pathway analyses. It is therefore important to identify genes 
with insufficient, inconclusive and low-quality evidence for 
involvement in the aetiology of male infertility. Recently, 
a systematic clinical validity assessment of all evidence 
available for gene-disease relationships in male infertility 
was performed (Oud et al. 2019). Based on a previously 
published method (Smith et al. 2017), 92 genes were clas-
sified as at least moderately linked to a human male infer-
tility phenotype. This included only 18% of all 521 gene-
disease relationships described in male infertility at that 
Fig. 2  Breakdown of genetic tools used in published male infertility 
studies over the past decade. Based on an analysis of all published 
literature related to monogenic forms of male infertility, Sanger 
sequencing was the predominant tool used (82%) in 2010 but has 
since then seen a reduced usage down to 26% in 2019. In the same 
time period, NGS-based techniques gained ground to become cur-
rently the most common tool (61%)
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time, demonstrating that the quality and extent of evidence 
varies greatly.
In the years to come, the number of novel genes described 
for male infertility is expected to increase rapidly as NGS 
methods become even more widely and frequently used. It 
is therefore important to continue adding and regularly re-
assessing the genetic and functional evidence for all genes 
described (Soraggi et al. 2020; Houston et al. 2020).
Recent developments in functional validation
The proper design of functional validation experiments, as 
well as reliance on previously developed functional mod-
els with male infertility phenotypes, are critical for the 
validation of newly identified variants. The emergence of 
new techniques for gene editing and the implementation of 
novel model organism and in vitro systems for the study of 
spermatogenesis has and will continue to expand our ability 
to perform the critical step of functional validation (Fig. 3).
In many diseases, in vitro modelling systems are widely 
used and highly effective in screening large numbers of 
variants across multiple genes. Additionally, in many cases 
in vitro systems can be established from individuals carrying 
a specific variant, enabling the direct assessment of the func-
tional impact of the variant. However, despite significant 
efforts, the development of in vitro spermatogenesis systems 
in humans has proven elusive to date (Komeya et al. 2018). 
The ability to culture and maintain the function of human 
Fig. 3  Mutagenesis techniques for functional validation and exam-
ples in male infertility research. Outline of the current mutagenesis 
techniques for functional validation, and the approximate year of 
application. Comparison of the main characteristics of the described 
techniques and some published examples of the application of these 
technologies in male infertility research
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testicular tissue would enable the functional validation of 
novel variants, and perhaps the modification of variants that 
cause azoospermia, potentially enabling the restoration of 
spermatogenic capacity in the not-too-distant future (Sato 
et al. 2011; Ibtisham et al. 2017).
While in vitro systems are not well established for the 
study of male infertility, the application of gene editing 
tools in a variety of model organisms has proven effective 
in the functional validation of suspected infertility-causing 
variants. For example, in the mouse, N-ethyl-N-nitrosou-
rea (ENU), an alkylating agent that induces genome-wide 
mutagenesis at random loci (Lewis et al. 1992; Stainier et al. 
2017), has been successfully used for the identification of 
novel genes required for male fertility. Following random 
mutagenesis by ENU, mice displaying an infertility pheno-
type are subsequently screened by a variety of approaches, 
including selective breeding and linkage analysis, and more 
recently whole genome sequencing, to identify the mutations 
underlying reproductive defects (Kennedy and O’Bryan 
2006; Jamsai and O’Bryan 2010; Geister et al. 2018).
In cases where a candidate variant has been identified 
and requires functional validation, a variety of targeted 
approaches can nowadays be applied. These approaches 
include the use of morpholino oligonucleotides for relatively 
short-term suppression of gene activity, zinc finger nucle-
ases (ZFN), transcription activator-like effector nucleases 
(TALEN) and Clustered regularly interspaced short palin-
dromic repeats (CRISPR) (Summerton 1999; Gaj et al. 2013; 
Rumi et al. 2014; Ramanagoudr-Bhojappa et al. 2018; Anuar 
et al. 2019), which enable genomic modification to inactivate 
a gene through the introduction of a premature stop codon 
or frameshift mutation. Alternatively, these approaches can 
be used to recapitulate specific mutations, for example a 
missense mutation that is predicted to be pathogenic (Gaj 
et al. 2013; Anzalone et al. 2019). While all of these tools 
have been applied successfully in male infertility research, 
the advantages of CRISPR in terms of cost, efficiency and 
simplicity have made this gene editing technology the tool 
of choice for most contemporary studies, and its use in male 
infertility research will certainly expand rapidly in the com-
ing years.
The enormous value of mouse knock-out experiments for 
the identification of human male infertility genes has already 
been highlighted in early studies (Lyon and Hawkes 1970; 
Yuan et al. 2000). For example, studies of the murine Klhl10 
gene, shown to be essential for spermiogenesis in mice, moti-
vated male infertility studies in humans and pointed to one of 
the few known examples of autosomal dominant male infer-
tility (Yan et al. 2004). After employing reverse-transcription 
PCR on RNA isolated from sperm of infertile and healthy 
men, two pathogenic-predicted KLHL10 missense mutations 
and one splicing mutation were identified by Sanger sequenc-
ing in severely oligozoospermic patients. Of note one fertile 
man was found to harbour one of these missense mutations, 
questioning the penetrance of this variant (Yatsenko et al. 
2006). Another example is hsf2, which was initially found to 
regulate normal spermatogenesis in mice (He et al. 2003) and 
it was only later that dominant negative heterozygous muta-
tions in the human orthologue HSF2 were found in infertile 
men by targeted NGS sequencing of this and ~ 600 other infer-
tility candidate genes (Mou et al. 2013).
Zebrafish have been used increasingly to model human dis-
eases including infertility. Lin et al. showed using a zebrafish 
model and Crispr/Cas9 that the amh gene is essential to control 
the balance between proliferation and differentiation of male 
germ cells (Lin et al. 2017). More recently CRISPR technol-
ogy was used to systematically characterize the function of 
17 Fanconi Anemia (FA) genes, revealing their essential role 
in growth, sexual development and fertility (Ramanagoudr-
Bhojappa et al. 2018). Studies like these are essential for the 
clinical validity assessment of genes related to male infertility 
and provide additional evidence for the role of recently identi-
fied mutations of these genes in azoospermic men (Kasak et al. 
2018; Krausz et al. 2019).
High throughput screens in Drosophila using ethyl-meth-
anesulfonate-induced mutations, similar to the ENU approach 
in mice (Wakimoto et al. 2004) or more recently RNA interfer-
ence (RNAi) knockdown (Yu et al. 2015) enabled the efficient 
identification of candidate infertility genes and downstream 
functional assessment of multiple candidate genes in a sin-
gle experiment. For example, discovery of the role of boule 
(homologous to human DAZ) in meiosis was first discovered 
in a large-scale mutation screen using drosophila (Castrillon 
et al. 1993; Eberhart et al. 1996).
Lastly, flagellated and ciliated unicellular organisms includ-
ing Chlamydomonas, Trypanosoma and Tetrahymena have 
been used to study the functional consequences of mutations in 
genes involved in sperm flagellar formation and function (e.g. 
CFAP43, CFAP44, ODA7, SPAG16L, and WDR66) in patients 
displaying MMAF (Zhang et al. 2006; Duquesnoy et al. 2009; 
Coutton et al. 2018; Kherraf et al. 2018). Yeast have likewise 
been an important model organism for the study of meiosis, 
enabling the identification of novel meiotic genes associated 
with male infertility, for example gda1 -orthologous to human 
ENTPD6 (Wang et al. 2015).
The use of gene editing tools in these and other model 
organisms will continue to be important in identifying and 
characterizing genetic variants associated with male infertility.
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The future: overcoming existing limitations 
to improve biological understanding, 
patient diagnostics and prognostics
The introduction of unbiased NGS approaches have revo-
lutionized the identification of genetic causes for many 
diseases (Payne et al. 2018; Bean et al. 2020). Although 
these methods are frequently used in research laboratories 
to study the genetics of male infertility, they have yet to 
identify the majority of genes underlying this disorder. For 
several types of male infertility such as DFS-MMAF, ace-
phalic sperm syndrome and globozoospermia, the current 
diagnostic yield based on known genetic causes explains 
approximately 50% of cases. In contrast, the diagnostic 
yield for the most common forms of male infertility, azoo-
spermia and oligozoospermia, remains much more limited 
(Krausz 2011; Tüttelmann et al. 2018; Krausz and Riera-
Escamilla 2018). Given the enormous potential of new 
genomic technologies in both research and diagnostics, 
how can we most efficiently improve our understanding of 
the genetics of male infertility? To conclude this review, 
we will discuss the limitations and pitfalls of current 
approaches and highlight some important new develop-
ments in genomic technologies and improvements in the 
organization of our research that should help to accelerate 
disease gene identification.
Challenges to gene discovery in a relatively common 
heterogeneous disorder
Exome and especially genome sequencing now allow us 
to perform unbiased genetic studies that can help to iden-
tify novel disease genes or genomic regions. The power to 
discover novel infertility genes is, however, still heavily 
influenced by a number of study design considerations. 
As with other disease models, careful phenotyping and 
cohort selection are critical. In addition, an understanding 
of the genetic architecture of the disease is important in 
designing appropriately powered studies. As previously 
discussed, discrete sperm morphological abnormalities are 
expected to involve a relatively modest number of genes, 
whereas a quantitative spermatogenic failure phenotype 
may arise from variants in any one of hundreds or even 
thousands of genes. In the case of extremely rare disorders 
with discrete phenotypes, a small case/control design may 
be appropriate, as it is likely that variants will be localized 
to a small number of genes. Genetic studies in consan-
guineous families have proven to be an effective means 
of identifying novel male infertility genes accounting for 
rare qualitative sperm defects. In cases of consanguinity, 
analyses can be focussed on regions of the genome that are 
homozygous by descent, as it is likely that rare recessive 
disease-causing mutations will exist in a homozygous state 
more frequently in these families (Okutman et al. 2015; 
Kasak et al. 2018).
In the investigation of NOA in outbred populations, it 
is likely that individual genes will harbour disease-causing 
variants at extremely low frequency in the patient popu-
lation, given the effect of the disease on overall fitness. 
In this case, large patient and control cohorts and robust 
statistical methods are essential to identify genes with an 
increased mutational load in the genome of affected patients, 
as was shown for other genetically heterogeneous disorders 
(Fitzgerald et al. 2015; Wilfert et al. 2016). This calls for 
large-scale collaborative studies and widespread data shar-
ing to reliably and robustly identify and functionally validate 
new male infertility genes.
International consortia have recently been established in 
the field of male infertility genetics to promote this, includ-
ing the GEMINI consortium (https ://gemin i.conra dlab.org/) 
and the IMIGC consortium (https ://www.imigc .org/). Col-
laboration, both within and beyond these consortia, will 
be essential to identify recurrently mutated genes, study 
detailed clinical presentations, perform relevant functional 
studies to confirm the pathogenicity of certain mutations and 
unravel the underlying biological mechanisms. Moreover, 
these consortia can help to replicate single case observations 
and confirm or question the role of new candidate genes in 
infertility, establish clinical guidelines and help to improve 
genetic diagnostics. Increased research collaboration can be 
a driver that benefits both our biological understanding as 
well as patient diagnostics in the field of male infertility.
Establishing the role of inherited and de novo 
mutations in infertility
So far, most research has focused on studying either auto-
somal recessive or X/Y-linked forms of male infertility. 
Severe male infertility cannot be dominantly inherited from 
fathers, but it can be maternally inherited or caused by de 
novo germline and post-zygotic mutations or CNVs. Exome 
and genome sequencing of patient-parent trios has revealed 
the importance of de novo germline mutations in many spo-
radic genetic diseases, in particular in intellectual disability 
and related disorders (Vissers et al. 2010, 2016; Veltman and 
Brunner 2012; McRae et al. 2017). This approach can be 
an immensely powerful means of identifying novel disease 
genes, but one of the main challenges for applications in 
male infertility research is that parental DNA samples are 
often unavailable. Recently, however, several groups have 
started to assemble cohorts of patient-parent trios for male 
infertility genetic research, aiming to identify de novo muta-
tions causing male infertility as well as providing insight 
into dominant maternal inheritance.
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Most NGS approaches use short-read sequencing which 
limits the detection of repeat structures (Schatz et  al. 
2010), highly homologous sequences and structural vari-
ation (Zhou et al. 2018; Ho et al. 2019). This affects male 
infertility research significantly, given the importance of 
chromosome microdeletions in highly homologous and 
repetitive regions on the Y chromosome as well as causal 
structural variation reported in other genomic regions. 
Recently, new sequencing platforms have emerged that 
have increased sequencing read lengths from a few hun-
dred nucleotides to 10 kb or even longer (Rhoads and Au 
2015; Gordon et al. 2016; Jiao et al. 2017). Because of 
their increased read length these platforms are much better 
able to detect repeat expansions, homologous sequences 
and structural genomic variation (Pendleton et al. 2015; 
Cretu Stancu et al. 2017). Unfortunately, the current per-
base accuracy and cost of these technologies does not 
yet compare favourably to short-read sequencing meth-
ods (Rhoads and Au 2015; Rang et al. 2018). Therefore, 
it is not yet possible to reliably and affordably ascertain 
all genetic variation present in the genome of an infertile 
patient in a single experiment. However, complete, accu-
rate and affordable human genome sequencing will likely 
be available in the next decade, and the major challenge 
in male infertility will become variant interpretation, not 
detection.
Conclusion
Significant progress has been made in our understanding of 
the genetics of male infertility. Using a variety of genomic 
technologies, the genes involved in rare qualitative sperm 
defects have now been largely identified, resulting in the 
development and application of NGS gene panels with a 
high diagnostic yield. Progress in our understanding of the 
genetics underlying the more common quantitative sperm 
defects has not been as rapid as we have seen in qualitative 
sperm defects or in other genetic disorders. The organi-
zation of large well-funded consortia studying thousands 
of patients with unbiased genomics approaches and the 
application of relevant functional validation assays should 
result in a much-needed breakthrough in this field in the 
coming years.
Acknowledgements This work was supported in part by the National 
Institutes of Health funding to K.I.A. (R01HD078641). This work was 
supported by a VICI grant from The Netherlands Organization for Sci-
entific Research (918-15-667 to J.A.V.), the Royal Society and Wolfson 
Foundation (WM160091 to J.A.V.) as well as an Investigator Award in 
Science from the Wellcome Trust (209451 to J.A.V.).
Compliance with ethical standards 
Conflict of interest On behalf of all authors, the corresponding author 
states that there is no conflict of interest.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
Akin JW, Behzadian A, Tho SPT, McDonough PG (1991) Evidence for 
a partial deletion in the androgen receptor gene in a phenotypic 
male with azoospermia. Am J Obstet Gynecol 165:1891–1894. 
https ://doi.org/10.1016/0002-9378(91)90052 -S
Anguiano A (1992) Congenital bilateral absence of the vas deferens. 
JAMA 267:1794. https ://doi.org/10.1001/jama.1992.03480 13011 
0034
Anuar ND, Kurscheid S, Field M et al (2019) Gene editing of the multi-
copy H2A.B gene and its importance for fertility. Genome Biol 
20:23. https ://doi.org/10.1186/s1305 9-019-1633-3
Anzalone AV, Randolph PB, Davis JR et al (2019) Search-and-replace 
genome editing without double-strand breaks or donor DNA. 
Nature 576:149–157. https ://doi.org/10.1038/s4158 6-019-1711-4
Aston KI, Carrell DT (2009) Genome-wide study of single-nucleotide 
polymorphisms associated with azoospermia and severe oligo-
zoospermia. J Androl 30:711–725. https ://doi.org/10.2164/jandr 
ol.109.00797 1
Ayhan Ö, Balkan M, Guven A et al (2014) Truncating mutations in 
TAF4B and ZMYND15 causing recessive azoospermia. J Med 
Genet 51:239–244. https ://doi.org/10.1136/jmedg enet-2013-
10210 2
Bean LJH, Funke B, Carlston CM et  al (2020) Diagnostic gene 
sequencing panels: from design to report—a technical standard 
of the American College of Medical Genetics and Genomics 
(ACMG). Genet Med 22:453–461. https ://doi.org/10.1038/s4143 
6-019-0666-z
Ben Khelifa M, Coutton C, Zouari R et  al (2014) Mutations in 
DNAH1, which encodes an inner arm heavy chain dynein, lead 
to male infertility from multiple morphological abnormalities 
of the sperm flagella. Am J Hum Genet 94:95–104. https ://doi.
org/10.1016/j.ajhg.2013.11.017
Bieth E, Hamdi SM, Mieusset R (2020) Genetics of the congenital 
absence of the vas deferens. Hum Genet. https ://doi.org/10.1007/
s0043 9-020-02122 -w
Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE (2013) Rare-
disease genetics in the era of next-generation sequencing: dis-




Brown TR, Lubahn DB, Wilson EM et al (1988) Deletion of the 
steroid-binding domain of the human androgen receptor gene 
in one family with complete androgen insensitivity syndrome: 
evidence for further genetic heterogeneity in this syndrome. 
Proc Natl Acad Sci 85:8151–8155. https ://doi.org/10.1073/
pnas.85.21.8151
Butz H, Nyírő G, Kurucz PA et al (2020) Molecular genetic diagnostics 
of hypogonadotropic hypogonadism: from panel design towards 
result interpretation in clinical practice. Hum Genet. https ://doi.
org/10.1007/s0043 9-020-02148 -0
Cangiano B, Swee DS, Quinton R, Bonomi M (2020) Genetics of 
congenital hypogonadotropic hypogonadism: peculiarities and 
phenotype of an oligogenic disease. Hum Genet. https ://doi.
org/10.1007/s0043 9-020-02147 -1
Castrillon DH, Gonczy P, Alexander S et al (1993) Toward a molecular 
genetic analysis of spermatogenesis in Drosophila melanogaster: 
characterization of male-sterile mutants generated by single P 
element mutagenesis. Genetics 135:489–505
Chapelle A, Hortling H, Niemi M, Wennström J (1964) XX sex chro-
mosomes in a human male. Acta Med Scand 175:25–38. https ://
doi.org/10.1111/j.0954-6820.1964.tb046 30.x
Chillón M, Casals T, Mercier B et al (1995) Mutations in the cystic 
fibrosis gene in patients with congenital absence of the vas def-
erens. N Engl J Med 332:1475–1480. https ://doi.org/10.1056/
NEJM1 99506 01332 2204
Coutton C, Vargas AS, Amiri-Yekta A et  al (2018) Mutations in 
CFAP43 and CFAP44 cause male infertility and flagellum 
defects in Trypanosoma and human. Nat Commun https ://doi.
org/10.1038/s4146 7-017-02792 -7
Coutton C, Zouari R, Abada F et al (2012) MLPA and sequence analy-
sis of DPY19L2 reveals point mutations causing globozoo-
spermia. Hum Reprod 27:2549–2558. https ://doi.org/10.1093/
humre p/des16 0
Cretu Stancu M, van Roosmalen MJ, Renkens I et al (2017) Map-
ping and phasing of structural variation in patient genomes 
using nanopore sequencing. Nat Commun 8:1326. https ://doi.
org/10.1038/s4146 7-017-01343 -4
Culard J-F, Desgeorges M, Costa P et al (1994) Analysis of the whole 
CFTR coding regions and splice junctions in azoospermic men 
with congenital bilateral aplasia of epididymis or vas deferens. 
Hum Genet 93:467–470. https ://doi.org/10.1007/BF002 01678 
Dam AHDM, Koscinski I, Kremer JAM et al (2007) Homozygous 
mutation in SPATA16 is associated with male infertility in 
human globozoospermia. Am J Hum Genet 81:813–820. https 
://doi.org/10.1086/52131 4
Dieterich K, Soto Rifo R, Faure AK et al (2007) Homozygous muta-
tion of AURKC yields large-headed polyploid spermatozoa 
and causes male infertility. Nat Genet 39:661–665. https ://doi.
org/10.1038/ng202 7
Dumur V, Gervais R, Rigot J-M et al (1990) Abnormal distribution 
of CF ΔF508 allele in azoospermic men with congenital apla-
sia of epididymis and vas deferens. Lancet 336:512. https ://doi.
org/10.1016/0140-6736(90)92066 -Q
Duquesnoy P, Escudier E, Vincensini L et al (2009) Loss-of-function 
mutations in the human ortholog of Chlamydomonas rein-
hardtii ODA7 disrupt dynein arm assembly and cause primary 
ciliary dyskinesia. Am J Hum Genet 85:890–896. https ://doi.
org/10.1016/j.ajhg.2009.11.008
Eberhart CG, Maines JZ, Wasserman SA (1996) Meiotic cell cycle 
requirement for a fly homologue of human deleted in Azoo-
spermia. Nature 381:783–785
Elliott DJ, Millar MR, Oghene K et al (1997) Expression of RBM in the 
nuclei of human germ cells is dependent on a critical region of 
the Y chromosome long arm. Proc Natl Acad Sci 94:3848–3853. 
https ://doi.org/10.1073/pnas.94.8.3848
Ferlin A, Arredi B, Foresta C (2006a) Genetic causes of male infertil-
ity. Reprod Toxicol 22:133–141. https ://doi.org/10.1016/j.repro 
tox.2006.04.016
Ferlin A, Moro E, Garolla A, Foresta C (1999) Human male infertility 
and Y chromosome deletions: role of the AZF-candidate genes 
DAZ, RBM and DFFRY. Hum Reprod 14:1710–1716. https ://
doi.org/10.1093/humre p/14.7.1710
Ferlin A, Vinanzi C, Garolla A et al (2006b) Male infertility and andro-
gen receptor gene mutations: clinical features and identification 
of seven novel mutations. Clin Endocrinol (Oxf) 65:606–610. 
https ://doi.org/10.1111/j.1365-2265.2006.02635 .x
Fernandez-Marmiesse A, Gouveia S, Couce ML (2018) NGS technolo-
gies as a turning point in rare disease research. Diagnosis and 
Treatment. Curr Med Chem https ://doi.org/10.2174/09298 67324 
66617 07181 01946 
Fitzgerald TW, Gerety SS, Jones WD et al (2015) Large-scale discov-
ery of novel genetic causes of developmental disorders. Nature 
519:223–228. https ://doi.org/10.1038/natur e1413 5
Gaj T, Gersbach CA, Barbas CF (2013) ZFN, TALEN, and CRISPR/
Cas-based methods for genome engineering. Trends Biotechnol 
31:397–405. https ://doi.org/10.1016/j.tibte ch.2013.04.004
Geister KA, Timms AE, Beier DR (2018) Optimizing genomic 
methods for mapping and identification of candidate vari-
ants in ENU mutagenesis screens using inbred mice. G3 
Genes Genomes Genet 8:401–409. https ://doi.org/10.1534/
g3.117.30029 2
Gershoni M, Hauser R, Barda S et al (2019) A new MEIOB muta-
tion is a recurrent cause for azoospermia and testicular meiotic 
arrest. Hum Reprod 34:666–671. https ://doi.org/10.1093/humre 
p/dez01 6
Gordon D, Huddleston J, Chaisson MJP et  al (2016) Long-read 
sequence assembly of the gorilla genome. Science 352:aae0344–
aae0344. https ://doi.org/10.1126/scien ce.aae03 44
Gottlieb B, Beitel LK, Nadarajah A et al (2012) The androgen receptor 
gene mutations database: 2012 update. Hum Mutat 33:887–894. 
https ://doi.org/10.1002/humu.22046 
Hamerton JL (1968) Robertsonian translocations in man: evidence for 
prezygotic selection. Cytogenet Genome Res 7:260–276. https 
://doi.org/10.1159/00012 9990
Harbuz R, Zouari R, Pierre V et al (2011) A recurrent deletion of 
DPY19L2 causes infertility in man by blocking sperm head elon-
gation and acrosome formation. Am J Hum Genet 88:351–361. 
https ://doi.org/10.1016/j.ajhg.2011.02.007
He H, Soncin F, Grammatikakis N et al (2003) Elevated expression of 
heat shock factor (HSF) 2A stimulates HSF1-induced transcrip-
tion during stress. J Biol Chem 278:35465–35475. https ://doi.
org/10.1074/jbc.M3046 63200 
Ho SS, Urban AE, Mills RE (2019) Structural variation in the 
sequencing era. Nat Rev Genet. https ://doi.org/10.1038/s4157 
6-019-0180-9
Houston BJ, Conrad DF, O’Bryan MK (2020) A framework for high-
resolution phenotyping of candidate male infertility mutants: 
from human to mouse. Hum Genet. https ://doi.org/10.1007/
s0043 9-020-02159 -x
Hutchison CA (2007) DNA sequencing: bench to bedside and beyond. 
Nucleic Acids Res 35:6227–6237. https ://doi.org/10.1093/nar/
gkm68 8
Ibtisham F, Wu J, Xiao M et al (2017) Progress and future prospect of 
in vitro spermatogenesis. Oncotarget 8:66709–66727. https ://doi.
org/10.18632 /oncot arget .19640 
Jacobs PA, Frackiewicz A, Law P et al (1975) The effect of struc-
tural aberrations of the chromosomes on reproductive fit-




Jacobs PA, Strong JA (1959) A case of human intersexuality having a 
possible XXY sex-determining mechanism. Nature 183:302–303. 
https ://doi.org/10.1038/18330 2a0
Jamsai D, O’Bryan MK (2010) Genome-wide ENU mutagenesis for 
the discovery of novel male fertility regulators. Syst Biol Reprod 
Med 56:246–259. https ://doi.org/10.3109/19396 36100 37064 24
Jiao Y, Peluso P, Shi J et al (2017) Improved maize reference genome 
with single-molecule technologies. Nature 546:524–527. https ://
doi.org/10.1038/natur e2297 1
Jungwirth A, Giwercman A, Tournaye H et  al (2012) European 
association of urology guidelines on male infertility: the 2012 
update. Eur Urol 62:324–332. https ://doi.org/10.1016/j.eurur 
o.2012.04.048
Kasak L, Laan M (2020) Monogenic causes of non-obstructive azoo-
spermia: challenges, established knowledge, limitations and 
perspectives. Hum Genet. https ://doi.org/10.1007/s0043 9-020-
02112 -y
Kasak L, Punab M, Nagirnaja L et al (2018) Bi-allelic recessive 
loss-of-function variants in FANCM cause non-obstructive 
azoospermia. Am J Hum Genet 103:200–212. https ://doi.
org/10.1016/j.ajhg.2018.07.005
Kennedy CL, O’Bryan MK (2006) N-ethyl-N-nitrosourea (ENU) 
mutagenesis and male fertility research. Hum Reprod Update 
12:293–301. https ://doi.org/10.1093/humup d/dmk00 4
Kerem B, Rommens J, Buchanan J et al (1989) Identification of the 
cystic fibrosis gene: genetic analysis. Science 245:1073–1080. 
https ://doi.org/10.1126/scien ce.25704 60
Kherraf Z-E, Amiri-Yekta A, Dacheux D et al (2018) A homozygous 
ancestral SVA-insertion-mediated deletion in WDR66 induces 
multiple morphological abnormalities of the sperm flagellum 
and male infertility. Am J Hum Genet 103:400–412. https ://
doi.org/10.1016/j.ajhg.2018.07.014
Kobayashi K, Mlzuno K, Hida A et al (1994) PCR analysis of the Y 
chromosome long arm in azoospermic patients: evidence for 
a second locus required for spermatogenesis. Hum Mol Genet 
3:1965–1967. https ://doi.org/10.1093/hmg/3.11.1965
Komeya M, Sato T, Ogawa T (2018) In vitro spermatogenesis: a 
century-long research journey, still half way around. Reprod 
Med Biol 17:407–420. https ://doi.org/10.1002/rmb2.12225 
Koscinski I, ElInati E, Fossard C et al (2011) DPY19L2 deletion as 
a major cause of Globozoospermia. Am J Hum Genet 88:344–
350. https ://doi.org/10.1016/j.ajhg.2011.01.018
Koulischer L, Schoysman R (1974) Chromosomes and human 
infertility. I. Mitotic and meiotic chromosome studies in 202 
consecutive male patients. Clin Genet 5:116–126. https ://doi.
org/10.1111/j.1399-0004.1974.tb016 73.x
Krausz C (2011) Male infertility: pathogenesis and clinical diagno-
sis. Best Pract Res Clin Endocrinol Metab 25:271–285. https 
://doi.org/10.1016/j.beem.2010.08.006
Krausz C, Casamonti E (2017) Spermatogenic failure and the Y chro-
mosome. Hum Genet 136:637–655. https ://doi.org/10.1007/
s0043 9-017-1793-8
Krausz C, Giachini C, Lo Giacco D et al (2012) High resolution 
X chromosome-SPECIFIC Array-CGH detects new CNVs in 
infertile males. PLoS ONE 7:e44887. https ://doi.org/10.1371/
journ al.pone.00448 87
Krausz C, Riera-Escamilla A (2018) Genetics of male infertility. 
Nat Rev Urol 15:369–384. https ://doi.org/10.1038/s4158 
5-018-0003-3
Krausz C, Riera-Escamilla A, Chianese C et al (2019) From exome 
analysis in idiopathic azoospermia to the identification of a 
high-risk subgroup for occult Fanconi anemia. Genet Med 
21:189–194. https ://doi.org/10.1038/s4143 6-018-0037-1
Lahn BT, Page DC (1997) Functional coherence of the human Y 
chromosome. Science 278:675–680. https ://doi.org/10.1126/
scien ce.278.5338.675
Lewis SE, Barnett LB, Shelby MD (1992) ENU mutagenesis in the 
mouse electrophoretic specific-locus test 2. Mutational stud-
ies of mature oocytes. Mutat Res Genet Toxicol 296:129–133. 
https ://doi.org/10.1016/0165-1110(92)90036 -9
Li L, Sha Y, Wang X et al (2017) Whole-exome sequencing iden-
tified a homozygous BRDT mutation in a patient with ace-
phalic spermatozoa. Oncotarget 8:19914–19922. https ://doi.
org/10.18632 /oncot arget .15251 
Lima AC, Carvalho F, Gonçalves J et al (2015) Rare double sex 
and mab-3-related transcription factor 1 regulatory variants in 
severe spermatogenic failure. Andrology 3:825–833. https ://
doi.org/10.1111/andr.12063 
Lin Q, Mei J, Li Z et al (2017) Distinct and cooperative roles of 
amh and dmrt1 in self-renewal and differentiation of male 
germ cells in Zebrafis. Genetics 207:1007–1022. https ://doi.
org/10.1534/genet ics.117.30027 4/-/DC1.1
Lo Giacco D, Chianese C, Ars E et al (2014) Recurrent X chromosome-
linked deletions: discovery of new genetic factors in male infer-
tility. J Med Genet 51:340–344. https ://doi.org/10.1136/jmedg 
enet-2013-10198 8
Lopes AM, Aston KI, Thompson E et al (2013) Human spermatogenic 
failure purges deleterious mutation load from the autosomes and 
both sex chromosomes, including the gene DMRT1. PLoS Genet 
9:e1003349. https ://doi.org/10.1371/journ al.pgen.10033 49
Lyon MF, Hawkes SG (1970) X-linked gene for testicular femi-
nization in the mouse. Nature 227:1217–1219. https ://doi.
org/10.1038/22712 17a0
Ma K, Inglis JD, Sharkey A et al (1993) A Y chromosome gene family 
with RNA-binding protein homology: candidates for the azoo-
spermia factor AZF controlling human spermatogenesis. Cell 
75:1287–1295. https ://doi.org/10.1016/0092-8674(93)90616 -X
Ma K, Sharkey A, Kirsch S et al (1992) Towards the molecular locali-
sation of the AZF locus: mapping of microdeletions in azoo-
spermic men within 14 subintervals of interval 6 of the human Y 
chromosome. Hum Mol Genet 1:29–33. https ://doi.org/10.1093/
hmg/1.1.29
Martinez-Garay I, Jablonka S, Sutajova M et al (2002) A new gene 
family (FAM9) of low-copy repeats in Xp22.3 expressed exclu-
sively in testis: implications for recombinations in this region. 
Genomics 80:259–267. https ://doi.org/10.1006/geno.2002.6834
McPhaul MJ, Marcelli M, Zoppi S et al (1992) Mutations in the ligand-
binding domain of the androgen receptor gene cluster in two 
regions of the gene. J Clin Invest 90:2097–2101. https ://doi.
org/10.1172/JCI11 6093
McRae JF, Clayton S, Fitzgerald TW et al (2017) Prevalence and archi-
tecture of de novo mutations in developmental disorders. Nature 
542:433–438. https ://doi.org/10.1038/natur e2106 2
Metzker ML (2005) Emerging technologies in DNA sequencing. 
Genome Res 15:1767–1776. https ://doi.org/10.1101/gr.37705 05
Miyamoto T, Hasuike S, Yogev L et al (2003) Azoospermia in patients 
heterozygous for a mutation in SYCP3. Lancet 362:1714–1719. 
https ://doi.org/10.1016/S0140 -6736(03)14845 -3
Mou L, Wang Y, Li H et al (2013) A dominant-negative mutation 
of HSF2 associated with idiopathic azoospermia. Hum Genet 
132:159–165. https ://doi.org/10.1007/s0043 9-012-1234-7
Nathanson KL, Kanetsky PA, Hawes R et al (2005) The Y deletion gr/
gr and susceptibility to testicular germ cell tumor. Am J Hum 
Genet 77:1034–1043. https ://doi.org/10.1086/49845 5
Okutman O, Muller J, Baert Y et al (2015) Exome sequencing reveals 
a nonsense mutation in TEX15 causing spermatogenic failure 
in a Turkish family. Hum Mol Genet 24:5581–5588. https ://doi.
org/10.1093/hmg/ddv29 0
Oud MS, Volozonoka L, Smits RM et al (2019) A systematic review 
and standardized clinical validity assessment of male infertility 




Patat O, Pagin A, Siegfried A et al (2016) Truncating mutations in the 
adhesion g protein-coupled receptor G2 Gene ADGRG2 cause an 
X-linked congenital bilateral absence of vas deferens. Am J Hum 
Genet 99:437–442. https ://doi.org/10.1016/j.ajhg.2016.06.012
Patrizio P, Ord T, Silber SJ, Asch RH (1993) Andrology: cystic fibrosis 
mutations impair the fertilization rate of epididymal sperm from 
men with congenital absence of the vas deferens. Hum Reprod 
8:1259–1263. https ://doi.org/10.1093/oxfor djour nals.humre 
p.a1382 37
Payne K, Gavan SP, Wright SJ, Thompson AJ (2018) Cost-effective-
ness analyses of genetic and genomic diagnostic tests. Nat Rev 
Genet 19:235–246. https ://doi.org/10.1038/nrg.2017.108
Pendleton M, Sebra R, Pang AWC et al (2015) Assembly and diploid 
architecture of an individual human genome via single-molecule 
technologies. Nat Methods 12:780–786. https ://doi.org/10.1038/
nmeth .3454
Pinkel D, Segraves R, Sudar D et al (1998) High resolution analysis 
of DNA copy number variation using comparative genomic 
hybridization to microarrays. Nat Genet 20:207–211. https ://
doi.org/10.1038/2524
Punab M, Poolamets O, Paju P et al (2016) Causes of male infertility: 
a 9-year prospective monocentre study on 1737 patients with 
reduced total sperm counts. Hum Reprod 32:18–31. https ://doi.
org/10.1093/humre p/dew28 4
Quigley CA, De BA, Marschke KB et al (1995) Androgen receptor 
defects: historical, clinical, and molecular perspectives. Endocr 
Rev 16:271–321. https ://doi.org/10.1210/edrv-16-3-271
Ramanagoudr-Bhojappa R, Carrington B, Ramaswami M et  al 
(2018) Multiplexed CRISPR/Cas9-mediated knockout of 19 
Fanconi anemia pathway genes in zebrafish revealed their 
roles in growth, sexual development and fertility. PLOS Genet 
14:e1007821. https ://doi.org/10.1371/journ al.pgen.10078 21
Rang FJ, Kloosterman WP, de Ridder J (2018) From squiggle to 
basepair: computational approaches for improving nanopore 
sequencing read accuracy. Genome Biol 19:90. https ://doi.
org/10.1186/s1305 9-018-1462-9
Reijo R, Alagappan RK, Page DC, Patrizio P (1996) Severe oli-
gozoospermia resulting from deletions of azoospermia factor 
gene on Y chromosome. Lancet 347:1290–1293. https ://doi.
org/10.1016/S0140 -6736(96)90938 -1
Reijo R, Lee T, Salo P et al (1995) Diverse spermatogenic defects in 
humans caused by Y chromosome deletions encompassing a 
novel RNA-binding protein gene. Nat Genet 10:383–393. https 
://doi.org/10.1038/ng089 5-383
Rhoads A, Au KF (2015) PacBio sequencing and its applica-
tions. Genomics Proteomics Bioinf 13:278–289. https ://doi.
org/10.1016/j.gpb.2015.08.002
Riordan RJ, Kerem B et al (1989) Identification of the cystic fibrosis 
gene: cloning and characterization of complementary DNA. 
Science 245:1066–1073. https ://doi.org/10.1126/scien ce.24759 
11
Rumi MAK, Dhakal P, Kubota K et al (2014) Generation of Esr1-
knockout rats using zinc finger nuclease-mediated genome edit-
ing. Endocrinology 155:1991–1999. https ://doi.org/10.1210/
en.2013-2150
Sato T, Katagiri K, Gohbara A et al (2011) In vitro production of 
functional sperm in cultured neonatal mouse testes. Nature 
471:504–507. https ://doi.org/10.1038/natur e0985 0
Saxena R, de Vries JWA, Repping S et al (2000) Four DAZ genes in 
two clusters found in the AZFc region of the human Y chro-
mosome. Genomics 67:256–267. https ://doi.org/10.1006/
geno.2000.6260
Schatz MC, Delcher AL, Salzberg SL (2010) Assembly of large 
genomes using second-generation sequencing. Genome Res 
20:1165–1173. https ://doi.org/10.1101/gr.10136 0.109
Schilit SLP, Menon S, Friedrich C et al (2020) SYCP2 translocation-
mediated dysregulation and frameshift variants cause human 
male infertility. Am J Hum Genet 106:41–57. https ://doi.
org/10.1016/j.ajhg.2019.11.013
Seabra CM, Quental S, Neto AP et al (2014) A novel Alu-mediated 
microdeletion at 11p13 removes WT1 in a patient with cryptor-
chidism and azoospermia. Reprod Biomed Online 29:388–391. 
https ://doi.org/10.1016/j.rbmo.2014.04.017
Sha Y-W, Wang X, Xu X et al (2019) Biallelic mutations in PMFBP1 
cause acephalic spermatozoa. Clin Genet 95:277–286. https ://
doi.org/10.1111/cge.13461 
Shen Y, Xu J, Yang X et al (2017) Evidence for the involvement of the 
proximal copy of the MAGEA9 gene in Xq28-linked CNV67 
specific to spermatogenic failure†. Biol Reprod 96:610–616. 
https ://doi.org/10.1093/biolr e/iox00 6
Skaletsky H, Kuroda-Kawaguchi T, Minx PJ et al (2003) The male-spe-
cific region of the human Y chromosome is a mosaic of discrete 
sequence classes. Nature 423:825–837. https ://doi.org/10.1038/
natur e0172 2
Smith ED, Radtke K, Rossi M et al (2017) Classification of genes: 
standardized clinical validity assessment of gene-disease associa-
tions aids diagnostic exome analysis and reclassifications. Hum 
Mutat 38:600–608. https ://doi.org/10.1002/humu.23183 
Solinas-Toldo S, Lampel S, Stilgenbauer S et  al (1997) Matrix-
based comparative genomic hybridization: Biochips to 
screen for genomic imbalances. Genes Chromosom Cancer 
20:399–407. https ://doi.org/10.1002/(SICI)1098-2264(19971 
2)20:4<399:AID-GCC12 >3.0.CO;2-I
Soraggi S, Riera M, Rajpert-De Meyts E et al (2020) Evaluating genetic 
causes of azoospermia: what can we learn from a complex cellu-
lar structure and single-cell transcriptomics of the human testis? 
Hum Genet. https ://doi.org/10.1007/s0043 9-020-02116 -8
Stainier DYR, Raz E, Lawson ND et al (2017) Guidelines for mor-
pholino use in zebrafish. PLOS Genet 13:e1007000. https ://doi.
org/10.1371/journ al.pgen.10070 00
Stouffs K, Vandermaelen D, Massart A et al (2012) Array comparative 
genomic hybridization in male infertility. Hum Reprod 27:921–
929. https ://doi.org/10.1093/humre p/der44 0
Summerton J (1999) Morpholino antisense oligomers: the case for an 
RNase H-independent structural type. Biochim Biophys Acta 
Gene Struct Expr 1489:141–158. https ://doi.org/10.1016/S0167 
-4781(99)00150 -5
Sun C, Skaletsky H, Birren B et al (1999) An azoospermic man with a 
de novo point mutation in the Y-chromosomal gene USP9Y. Nat 
Genet 23:429–432. https ://doi.org/10.1038/70539 
Talkowski ME, Ernst C, Heilbut A et  al (2011) Next-generation 
sequencing strategies enable routine detection of balanced 
chromosome rearrangements for clinical diagnostics and 
genetic research. Am J Hum Genet 88:469–481. https ://doi.
org/10.1016/j.ajhg.2011.03.013
Tewes A-C, Ledig S, Tüttelmann F et al (2014) DMRT1 mutations are 
rarely associated with male infertility. Fertil Steril 102:816–820.
e3. https ://doi.org/10.1016/j.fertn stert .2014.05.022
Therkelsen A (1964) Sterile male with the chromosome constitu-
tion 46 XX. Cytogenet Genome Res 3:207–218. https ://doi.
org/10.1159/00012 9812
Tiepolo L, Zuffardi O (1976) Localization of factors controlling 
spermatogenesis in the nonfluorescent portion of the human 
y chromosome long arm. Hum Genet 34:119–124. https ://doi.
org/10.1007/BF002 78879 
Touré A, Martinez G, Kherraf Z-E et al (2020) The genetic architecture 
of morphological abnormalities of the sperm tail. Hum Genet. 
https ://doi.org/10.1007/s0043 9-020-02113 -x
Tournaye H, Krausz C, Oates RD (2017) Novel concepts in 
the aetiology of male reproductive impairment. Lancet 
Human Genetics 
1 3
Diabetes Endocrinol 5:544–553. https ://doi.org/10.1016/S2213 
-8587(16)30040 -7
Tüttelmann F, Ruckert C, Röpke A (2018) Disorders of spermatogen-
esis. Medizinische Genet 30:12–20. https ://doi.org/10.1007/
s1182 5-018-0181-7
Tüttelmann F, Simoni M, Kliesch S et al (2011) Copy number vari-
ants in patients with severe oligozoospermia and sertoli-cell-only 
syndrome. PLoS ONE 6:e19426. https ://doi.org/10.1371/journ 
al.pone.00194 26
Veltman JA, Brunner HG (2012) De novo mutations in human genetic 
disease. Nat Rev Genet 13:565–575. https ://doi.org/10.1038/
nrg32 41
Visser L, Westerveld GH, Korver CM et al (2009) Y chromosome gr/
gr deletions are a risk factor for low semen quality. Hum Reprod 
24:2667–2673. https ://doi.org/10.1093/humre p/dep24 3
Vissers LELM, de Ligt J, Gilissen C et al (2010) A de novo paradigm 
for mental retardation. Nat Genet 42:1109–1112. https ://doi.
org/10.1038/ng.712
Vissers LELM, Gilissen C, Veltman JA (2016) Genetic studies in intel-
lectual disability and related disorders. Nat Rev Genet 17:9–18. 
https ://doi.org/10.1038/nrg39 99
Vockel M, Riera-Escamilla A, Tüttelmann F, Krausz C (2019) The 
X chromosome and male infertility. Hum Genet. https ://doi.
org/10.1007/s0043 9-019-02101 -w
Vogt P, Chandley AC, Hargreave TB et al (1992) Microdeletions in 
interval 6 of the Y chromosome of males with idiopathic steril-
ity point to disruption of AZF, a human spermatogenesis gene. 
Hum Genet 89:491–496. https ://doi.org/10.1007/BF002 19172 
Vogt PH (1998) Human chromosome deletions in Yq11, AZF candi-
date genes and male infertility: history and update. Mol Hum 
Reprod 4:739–744. https ://doi.org/10.1093/moleh r/4.8.739
Wakimoto BT, Lindsley DL, Herrera C (2004) Toward a compre-
hensive genetic analysis of male fertility in Drosophila mela-
nogaster. Genetics 167:207–216. https ://doi.org/10.1534/genet 
ics.167.1.207
Wang Q, Liu C, Tang C et al (2015) Yeast model identifies ENTPD6 
as a potential non-obstructive azoospermia pathogenic gene. Sci 
Rep 5:1–13. https ://doi.org/10.1038/srep1 1762
Weiske W-H, Sälzler N, Schroeder-Printzen I, Weidner W (2000) 
Clinical findings in congenital absence of the vasa deferentia. 
Andrologia 32:13–18. https ://doi.org/10.1111/j.1439-0272.2000.
tb028 59.x
Wilfert AB, Chao KR, Kaushal M et al (2016) Genome-wide signifi-
cance testing of variation from single case exomes. Nat Genet 
48:1455–1461. https ://doi.org/10.1038/ng.3697
Yan W, Ma L, Burns KH, Matzuk MM (2004) Haploinsufficiency of 
kelch-like protein homolog 10 causes infertility in male mice. 
Proc Natl Acad Sci 101:7793–7798. https ://doi.org/10.1073/
pnas.03080 25101 
Yang F, Gell K, van der Heijden GW et al (2008) Meiotic failure in 
male mice lacking an X-linked factor. Genes Dev 22:682–691. 
https ://doi.org/10.1101/gad.16136 08
Yang F, Silber S, Leu NA et al (2015) TEX 11 is mutated in infertile 
men with azoospermia and regulates genome-wide recombina-
tion rates in mouse. EMBO Mol Med 7:1198–1210. https ://doi.
org/10.15252 /emmm.20140 4967
Yang Y, Guo J, Dai L et al (2018) XRCC2 mutation causes meiotic 
arrest, azoospermia and infertility. J Med Genet 55:628–636. 
https ://doi.org/10.1136/jmedg enet-2017-10514 5
Yatsenko AN, Georgiadis AP, Röpke A et al (2015) X-linked TEX11 
mutations, meiotic arrest, and azoospermia in infertile men. N 
Engl J Med 372:2097–2107. https ://doi.org/10.1056/NEJMo 
a1406 192
Yatsenko AN, Roy A, Chen R et al (2006) Non-invasive genetic diag-
nosis of male infertility using spermatozoal RNA: KLHL10muta-
tions in oligozoospermic patients impair homodimerization. Hum 
Mol Genet 15:3411–3419. https ://doi.org/10.1093/hmg/ddl41 7
Yen PH (1998) A long-range restriction map of deletion interval 6 
of the human Y chromosome: a region frequently deleted in 
azoospermic males. Genomics 54:5–12. https ://doi.org/10.1006/
geno.1998.5526
Yu J, Wu H, Wen Y et al (2015) Identification of seven genes essential 
for male fertility through a genome-wide association study of 
non-obstructive azoospermia and RNA interference mediated 
large-scale functional screening in Drosophila. Hum Mol Genet 
24:1493–1503. https ://doi.org/10.1093/hmg/ddu55 7
Yuan L, Liu J-G, Zhao J et al (2000) The murine SCP3 gene is required 
for synaptonemal complex assembly, chromosome synapsis, and 
male fertility. Mol Cell 5:73–83. https ://doi.org/10.1016/S1097 
-2765(00)80404 -9
Zhang Z, Kostetskii I, Tang W et al (2006) Deficiency of SPAG16L 
causes male infertility associated with impaired sperm motil-
ity. Biol Reprod 74:751–759. https ://doi.org/10.1095/biolr eprod 
.105.04925 4
Zhou B, Ho SS, Zhang X et al (2018) Whole-genome sequencing anal-
ysis of CNV using low-coverage and paired-end strategies is effi-
cient and outperforms array-based CNV analysis. J Med Genet 
55:735–743. https ://doi.org/10.1136/jmedg enet-2018-10527 2
Zhu F, Wang F, Yang X et  al (2016) Biallelic SUN5 mutations 
cause autosomal-recessive acephalic spermatozoa syndrome. 
Am J Hum Genet 99:942–949. https ://doi.org/10.1016/j.
ajhg.2016.08.004
Zhu F, Liu C, Wang F et al (2018) Mutations in PMFBP1 cause ace-
phalic spermatozoa syndrome. Am J Hum Genet 103:188–199. 
https ://doi.org/10.1016/j.ajhg.2018.06.010
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
